News & Updates
Filter by Specialty:
Foetoplacental factors predict hypertension in early childhood
Foetal growth deceleration and high foetoplacental vascular resistance both contribute to an increased risk of prehypertension and hypertension in children, a study has found.
Foetoplacental factors predict hypertension in early childhood
05 Nov 2022
Slow disease progression seen in people with NAFLD
A 23-year longitudinal follow-up in a population-based cohort has shown a slowly progressive trend in nonalcoholic fatty liver disease (NAFLD), with liver-related outcomes affecting only a small number of people, reports a recent study.
Slow disease progression seen in people with NAFLD
05 Nov 2022
COSMIC-313: Adding cabozantinib to nivo-ipi may improve PFS in advanced RCC
The combination of nivolumab, ipilimumab, and cabozantinib improved progression-free survival (PFS) in patients with previously untreated, advanced renal cell carcinoma (RCC) of intermediate or poor risk as per IMDC* criteria, results of the phase III COSMIC-313 trial showed.
COSMIC-313: Adding cabozantinib to nivo-ipi may improve PFS in advanced RCC
04 Nov 2022
Once-a-day pill as switch option receives thumbs up across multiple HIV populations
Switching to the once-a-day, fixed-dose pill that contains bictegravir, emtricitabine, and tenofovir (BIC/FTC/TAF) appears to be safe and effective in older HIV patients and in people living with HIV (PLHIV) with pretreatment or treatment-acquired resistance, in addition to yielding metabolic benefits, according to studies presented at HIV Glasgow 2022.